MwanzoINDGN • NSE
add
Indegene Ltd
Bei iliyotangulia
₹ 632.75
Bei za siku
₹ 633.60 - ₹ 653.50
Bei za mwaka
₹ 470.10 - ₹ 736.30
Thamani ya kampuni katika soko
155.52B INR
Wastani wa hisa zilizouzwa
elfu 618.87
Uwiano wa bei na mapato
37.77
Mgao wa faida
-
Ubadilishanaji wa msingi
NSE
Habari za soko
The Straits Times
siku 1 iliyopita
Nasdaq closes lower, S&P 500 up slightly as US yields stay elevated
1.38%
0.55%
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 6.87B | 8.04% |
Matumizi ya uendeshaji wa biashara | 5.80B | 8.55% |
Mapato halisi | 917.00M | 22.27% |
Kiwango cha faida halisi | 13.35 | 13.14% |
Mapato kwa kila hisa | — | — |
EBITDA | 1.26B | 14.33% |
Asilimia ya kodi ya mapato | 26.11% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 14.67B | — |
Jumla ya mali | 30.24B | — |
Jumla ya dhima | 6.64B | — |
Jumla ya hisa | 23.60B | — |
hisa zilizosalia | 238.80M | — |
Uwiano wa bei na thamani | 6.40 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | 12.22% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 917.00M | 22.27% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Indegene Limited is an Indian company that provides research and commercialization services to biopharmaceutical and healthcare enterprises. Based in Bangalore, the company provides consulting in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1998
Tovuti
Wafanyakazi
4,367
